期刊文献+

标本类型及存放时间对心衰患者BNP和NT-proBNP检测结果的影响 被引量:18

The Effects of Specimen Type and Storage Time on the Test Results of BNP and NT-proBNP in Heart Failure Patients
下载PDF
导出
摘要 目的:探讨标本类型及存放时间对心衰患者B型尿钠肽(BNP)和氨基末端B型尿钠肽前体(NT-proBNP)检测结果的影响。方法:取37例心衰患者静脉血,制备EDTA-K2抗凝血浆、肝素钠抗凝血浆和血清标本,同时进行BNP与NT-proBNP平行测定,并将EDTA-K2抗凝血浆标本于室温(22℃±3℃)监测上述指标在0~24h的水平稳定性。结果:采用血清及EDTA-K2和肝素钠抗凝血浆标本检测NT-proBNP结果重复性好,而BNP结果的重复性较差;EDTA-K2抗凝血浆在室温下放置0~24h,BNP浓度逐渐下降,24h与0h、2h比较,差异显著(P<0.05);而NT-proBNP浓度在0~24h维持不变。结论:NT-proBNP测定的适用标本类型较多,且检测结果比BNP稳定,建议诊断心衰时选择NT-proBNP作为辅助检测指标。 Objective:To study the effects of specimen type and storage time on the test results of B-type natriuretic peptide(BNP)and N-terminal proBNP(NT-proBNP)in heart failure patients.Method:BNP and NT-proBNP were determined in 37 patients with heart failure.Specimen were prepared as EDTA-K2 anticoagulant plasma,heparin anticoagulant plasma and serum.BNP and NT-proBNP measured in parallel;To monitor the stability of BNP and NT-proBNP,we placed the EDTA-K2 anticoagulant plasma samples at room temperature(22℃±3℃)for 0~24h.Results:In serum,EDTA-K2 anticoagulation sample and heparin sodium anticoagulation sample,the test results of NT-proBNP had a good reproducibility,while BNP was poor;Placing the EDTA-K2 anticoagulant plasma at room temperature for 0 ~ 24h,the concentration of BNP decreased gradually,24h and 0h,2h had significant difference(P<0.05);While the concentration of NT-proBNP almost unchanged.Conclusion:NT-proBNP can be tested in most type of specimen.Compared with BNP,it was more stable.So NT-proBNP was suggested as a marker for the diagnosis of heart failure.
出处 《微循环学杂志》 2010年第2期37-38,共2页 Chinese Journal of Microcirculation
关键词 PROBNP 检测结果 NT 心衰患者 存放时间 标本类型 PEPTIDE B型尿钠肽 BNP NT-proBNP Heart failure Specimen type Storage time
  • 相关文献

参考文献5

  • 1Tang WH,Francis GS,Morrow DA,et al.National academy of clinical biochemistry laboratory medicine practice guidelines:clinical utilization of cardiac biomarker testing in heart failure.Circulation,2007,116(5):e99-el09.
  • 2Troaghton RW,Frampton CM,Yandte TG,et al.Treatment of heart failure guided by plasma aminotemfina brain natriuretie peptide concentrations.Lancet,2000,355(9210):1 126-1 130.
  • 3Yeo KT,Wu AH,Apple FS,et al.Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.Clin Chem Acta,2003,338(1-2):107-115.
  • 4Wu AH,Packer M,Smith A,et al.Analytical and clinical evaluation of the bayer ADVIA centaur automated B-Type natriuretic peptide assay in patients with heart failure:a multisite study.Clinical Chemistry,2004,50(5):867-873.
  • 5朱丽萍,徐丽珍,黄萃,陈日秋.慢性肾功能衰竭患者血浆BNP的临床观察[J].放射免疫学杂志,2008,21(3):228-229. 被引量:3

二级参考文献8

  • 1王彩丽,魏枫,史平,李桂玲.慢性炎症反应对慢性肾功能衰竭患者并发症的影响[J].放射免疫学杂志,2006,19(1):18-21. 被引量:9
  • 2王海燕 郑法雷 等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,2:131-134.
  • 3McCullough PA, Omland T, Maisel As. B -type natriuretic peptides: a diagnostic breakthrough for clinlcans. Rev Canliovasc Med. 2002, 4(2) :72.
  • 4Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family.Lancet. 1997,349:1307.
  • 5McClluogh PA, Duc P, Omland T. B -type naturiretic peptidos and renal function in the diagnosis of heart failure: an analysis from the breathing. Not Properly Multinational Study . Am J Kidney Dis. 2003, 41:571.
  • 6Bergstrom J, Lindholm B. Malnutrition cardiac disease and mortality: an integrated point of view. Am J Kidney Dis. 1998, 32(5) :834.
  • 7Schaufe Lberger Maria, Bergh Clase - Hakan, Caidahl. Can brain natrinreic peptide (BNP) be used as a screening tool in general practice. Scandinavian Journal of Primary Health Care. 2004,22(3) :187.
  • 8杨传高,李红霞,周亚峰,宋建平.血浆脑利钠肽浓度与高血压病左室肥厚及心功能的关系[J].苏州大学学报(医学版),2004,24(2):193-194. 被引量:13

共引文献2

同被引文献141

引证文献18

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部